TEAS RF New Application

PTO Form 1478 (Rev 9/2006)

OMB No. 0651-0009 (Exp 02/28/2018)

---

PTO Form 1478 (Rev 9/2006)

OMB No. 0651-0009 (Exp 02/28/2018)

Trademark/Service Mark Application, Principal Register

Serial Number: 86734365

Filing Date: 08/24/2015

To the Commissioner for Trademarks:

MARK: COSENTYX (Standard Characters, see mark)
The literal element of the mark consists of COSENTYX.
The mark consists of standard characters, without claim to any particular font, style, size, or color.

The applicant, Novartis AG, a corporation of Switzerland, having an address of
      CH-4002
      Basel
      Switzerland


requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Anti-inflammatories; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in rheumatology
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 4716891 and 4427248.

Significance of wording, letter(s), or numeral(s)
COSENTYX appearing in the mark has no significance nor is it a term of art in the relevant trade or industry or as used in connection with the goods/services listed in the application, or any geographical significance. The word(s) COSENTYX has no meaning in a foreign language.

The applicant's current Attorney Information:
      Maury M. Tepper, III and Kathryn M. Eyster of Tepper & Eyster, PLLC
      3724 Benson Drive
      Raleigh, North Carolina 27609
      United States


The applicant hereby appoints Novartis Pharmaceuticals Corporation
      One Health Plaza, Bldg. 430
      East Hanover New Jersey 07936
      United States
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.

The applicant's current Correspondence Information:

Maury M. Tepper, III

Tepper & Eyster, PLLC

3724 Benson Drive

Raleigh, North Carolina 27609

9198618903(phone)

9198618913(fax)

mtepper@teiplaw.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or applicant's attorney at the e-mail address provided above. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in an additional processing fee of $50 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

The signatory believes that: if the applicant is filing the application under 15 U.S.C. § 1051(a), the applicant is the owner of the trademark/service mark sought to be registered; the applicant is using the mark in commerce on or in connection with the goods/services in the application; the specimen(s) shows the mark as used on or in connection with the goods/services in the application; and/or if the applicant filed an application under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e), the applicant is entitled to use the mark in commerce; the applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the goods/services in the application. The signatory believes that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive. The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Maury M. Tepper, III/   Date: 08/24/2015
Signatory's Name: Maury M. Tepper, III
Signatory's Position: Attorney of Record, NC Bar Member
RAM Sale Number: 86734365
RAM Accounting Date: 08/25/2015

Serial Number: 86734365
Internet Transmission Date: Mon Aug 24 13:56:42 EDT 2015
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-201508241356424
83066-86734365-540fdd6f4f0e3622f8e4dcfff
c6e75da5203ad8fcc517b130b1109e33bcf247ea
-CC-269-20150824093542344674